Abstract

Despite recent evidence, the role of human papillomavirus (HPV) in breast carcinogenesis is controversial. The correlations of HPV infection with the clinicopathological features of breast cancer and the expression of cell cycle/apoptosis-associated proteins have not been well elucidated. In this study, we sought to determine the prevalence of high-risk HPVs (HR-HPVs) infection and BCL2, p21, p53, Rb, and survivin expression in breast cancer patients and to investigate the relationship of HPV with these cancer-related proteins, in an attempt to clarify the potential mechanism of HPV in breast cancer pathogenesis. HPV presence in 81 fresh breast cancer tissues was determined by hybrid capture 2 (HC2) assay, and expression of BCL2, p21, p53, Rb, and survivin was detected by immunohistochemistry. Here we showed that fourteen (17.3%) patients were HR-HPV positive. HPV infection demonstrated no significant correlation with the clinicopathological characteristics of breast cancer. HPV-positive tumors showed significantly higher BCL2 and lower p53 expression than HPV-negative tumors. Expression of p21, Rb, and survivin was not associated with HPV status. Our results suggest a possible role of HR-HPV in breast cancer carcinogenesis, in which BCL2 and p53 may be involved.

Highlights

  • Recent studies have reported that some viruses such as Epstein-Barr virus (EBV) and mouse mammary tumor virus (MMTV), as well as human papillomavirus (HPV), may play important roles in breast cancer development and progression [1]

  • High-risk HPVs were detected in 14 (17.3%) of 81 fresh breast cancer specimens, which is in accordance with a systematic review study conducted on European (13.4%) and America Central and South American

  • Haghshenas et al reported that prevalence of HPV infection among Iranian women with breast cancer was 23.6% [25]

Read more

Summary

Introduction

Recent studies have reported that some viruses such as Epstein-Barr virus (EBV) and mouse mammary tumor virus (MMTV), as well as human papillomavirus (HPV), may play important roles in breast cancer development and progression [1]. The relationship between HPV and other types of cancers, including cervix, vagina, vulva, head and neck, anal, and penile carcinomas, has been well established [2]. Reports on the association between HPV and breast cancer were controversial. The prevalence of HPV in breast cancer tissues ranged from 0 to 86% [3]. A number of studies have supported the involvement of HPV in breast cancer, several other investigations did not detect any HPV subtypes in breast cancer tissues [4]. It is important to further clarify the role and mechanism of HPV in breast cancer

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call